Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/335223
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Unveiling behavioral and molecular neuroadaptations related to the antidepressant action of cannabidiol in the unpredictable chronic mild stress model |
Autor: | García-Gutiérrez, María Salud CSIC ORCID; Navarro, Daniela CSIC ORCID; Austrich-Olivares, Amaya CSIC; Manzanares, Jorge CSIC ORCID CVN | Fecha de publicación: | 2023 | Editor: | Frontiers Media | Citación: | Frontiers in Pharmacology 14: 1171646 (2023) | Resumen: | [Introduction]: This study aims to further characterize cannabidiol’s pharmacological and molecular profile as an antidepressant. [Methods]: Effects of cannabidiol (CBD), alone or combined with sertraline (STR), were evaluated in male CD1 mice (n = 48) exposed to an unpredictable chronic mild stress (UCMS) procedure. Once the model was established (4 weeks), mice received CBD (20 mg·kg-1, i.p.), STR (10 mg·kg-1, p.o.) or its combination for 28 days. The efficacy of CBD was evaluated using the light-dark box (LDB), elevated plus maze (EPM), tail suspension (TS), sucrose consumption (SC) and novel object recognition (NOR) tests. Gene expression changes in the serotonin transporter, 5-HT1A and 5-HT2A receptors, BDNF, VGlut1 and PPARdelta, were evaluated in the dorsal raphe, hippocampus (Hipp) and amygdala by real-time PCR. Besides, BDNF, NeuN and caspase-3 immunoreactivity were assessed in the Hipp. [Results]: CBD exerted anxiolytic and antidepressant-like effects at 4 and 7 days of treatment in the LDB and TS tests, respectively. In contrast, STR required 14 days of treatment to show efficacy. CBD improved cognitive impairment and anhedonia more significantly than STR. CBD plus STR showed a similar effect than CBD in the LBD, TST and EPM. However, a worse outcome was observed in the NOR and SI tests. CBD modulates all molecular disturbances induced by UCMS, whereas STR and the combination could not restore 5-HT1A, BDNF and PPARdelta in the Hipp. [Discussion]: These results pointed out CBD as a potential new antidepressant with faster action and efficiency than STR. Particular attention should be given to the combination of CBD with current SSRI since it appears to produce a negative impact on treatment. |
Versión del editor: | https://doi.org/10.3389/fphar.2023.1171646 | URI: | http://hdl.handle.net/10261/335223 | DOI: | 10.3389/fphar.2023.1171646 | E-ISSN: | 1663-9812 |
Aparece en las colecciones: | (IN) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
unveilingmodel.pdf | 3,61 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
1
checked on 10-abr-2024
SCOPUSTM
Citations
1
checked on 01-may-2024
Page view(s)
29
checked on 29-abr-2024
Download(s)
12
checked on 29-abr-2024